CV Sciences (CVSI) Amortization of Deferred Charges (2015 - 2018)
CV Sciences' (CVSI) quarterly Amortization of Deferred Charges came in at $926.0 in Q4 2018, down 98.39% year-on-year from $57401.0 in Q4 2017, and down 98.15% quarter-over-quarter from $50074.0 in Q2 2018.
CV Sciences (CVSI) Amortization of Deferred Charges (2015 - 2018) Analysis & Trends
CV Sciences has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $926.0 for Q4 2018.
- Amortization of Deferred Charges for Q4 2018 came in at $926.0, down 98.39% year-over-year; the trailing twelve-month figure through Dec 2018 was $51000.0 (down 76.92% YoY), and the FY2018 annual result was $51000.0, down 76.92% from the prior year.
- Amortization of Deferred Charges came in at $926.0 for Q4 2018 at CV Sciences, down from $50074.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $172866.0 in Q4 2015 to a low of $926.0 in Q4 2018.
- The 4-year median for Amortization of Deferred Charges is $57882.0 (2016), against an average of $63516.4.
- Across the five-year window, Amortization of Deferred Charges soared 201.0% in 2016 and sank 98.39% in 2018, its largest moves.
- CV Sciences' Amortization of Deferred Charges stood at $172866.0 in 2015, then tumbled by 66.52% to $57883.0 in 2016, then declined by 0.83% to $57401.0 in 2017, then tumbled by 98.39% to $926.0 in 2018.
- The last three Amortization of Deferred Charges figures came in at $926.0 (Q4 2018), $50074.0 (Q2 2018), and $57401.0 (Q4 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 926.00 |
| Dec 31, 2018 | 926.00 |
| Jun 30, 2018 | 50,074.00 |
| Jun 30, 2018 | 50,074.00 |
| Dec 31, 2017 | 57,401.00 |
| Dec 31, 2017 | 57,401.00 |
| Sep 30, 2017 | 43,707.00 |
| Sep 30, 2017 | 43,707.00 |
| Jun 30, 2017 | 60,580.00 |
| Jun 30, 2017 | 60,580.00 |
| Mar 31, 2017 | 59,312.00 |
| Mar 31, 2017 | 59,312.00 |
| Dec 31, 2016 | 57,883.00 |
| Dec 31, 2016 | 57,883.00 |
| Sep 30, 2016 | 57,882.00 |
| Sep 30, 2016 | 57,882.00 |
| Jun 30, 2016 | 47,163.00 |
| Jun 30, 2016 | 47,163.00 |
| Mar 31, 2016 | 126,086.00 |
| Mar 31, 2016 | 126,086.00 |